MiRus

MiRus is a privately held medical device company focused on the design and development of innovative solutions for the treatment of spine, orthopaedic and structural heart diseases. The company leverages its proprietary Rhenium-based alloy called MoRe® to revolutionize medicine with safer, more durable implants and less invasive surgical procedures.

Founded in 2015 and headquartered in Marietta, Georgia, MiRus has created an integrated platform spanning pre-operative planning, intra-operative navigation, and post-operative monitoring solutions. The company's breakthrough MoRe® superalloy, made from Molybdenum-Rhenium, offers major advancements over traditional medical implant materials like titanium and cobalt chromium, enabling the development of smaller, stronger, and more durable implants with greater biocompatibility and significantly lower metal ion release.

MiRus has received multiple FDA clearances and approvals for its innovative products, including the Europa™ Pedicle Screw System and the CYGNUS™ Anterior Cervical Plate System. The company has also made significant strides in structural heart disease treatment with its SIEGEL™ Balloon Expandable Transcatheter Aortic Valve Replacement system. Backed by strong investor support including a major strategic investment from Boston Scientific, MiRus continues to advance its mission of creating a better future for patients living with cardiovascular and orthopaedic diseases.